Cancer risk associated with STK11/LKB1 germline mutations in Peutz–Jeghers syndrome patients: Results of an Italian multicenter study
Nicoletta Resta(University of Bari Aldo Moro), Maurizio Ponz de Leòn(University of Modena and Reggio Emilia), Daniela Turchetti(University of Bologna), Emanuele Urso(University of Padua), Angelo Andriulli(Casa Sollievo della Sofferenza), Daniela Pierannunzio(Istituto Superiore di Sanità), Maurizio Genuardi(University of Florence), Emanuela Lucci‐Cordisco, Carmela Di Gregorio, Lucio Bertario(European Institute of Oncology), Rosanna Bagnulo(University of Bari Aldo Moro), Cristina Host(Arcispedale Sant'Anna), Daria Carmela Loconte(University of Bari Aldo Moro), Alessandro Stella(University of Bari Aldo Moro), Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), Ada Piepoli(Istituti di Ricovero e Cura a Carattere Scientifico), Laura Giunti(Meyer Children's Hospital), Francesco Susca(University of Bari Aldo Moro), Paola Grammatico(Nini Hospital), Paola Sala(Istituti di Ricovero e Cura a Carattere Scientifico), Mara Fornasarig(Centro di Riferimento Oncologico), Vittoria Stigliano, Gennaro Mariano Lenato(University of Bari Aldo Moro), Patrizia Lastella(University of Bari Aldo Moro), Riccardo Capocaccia(Departamento de Epidemiología), Maria Grazia Tibiletti(University of Insubria), Luigi Memo(Ospedale San Bortolo), Cristina Bozzao(University of Bari Aldo Moro), Alessandra Viel(Centro di Riferimento Oncologico), Carlo Sabbà(University of Bari Aldo Moro)
Cited by 158
Related Papers
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|486